Skip to main content
Interventional Neuroradiology logoLink to Interventional Neuroradiology
. 2021 Feb 16;27(5):716–721. doi: 10.1177/1591019921996510

Outpatient management of chronic expanding subdural hematomas with endovascular embolization to minimize inpatient admissions during the COVID-19 viral pandemic

Pouya Entezami 1,, Nicholas C Field 1, John C Dalfino 1
PMCID: PMC8490660  PMID: 33593143

Abstract

Chronic subdural hematomas are complex collections that usually form after a trauma, particularly in elderly patients. This vulnerable population is at increased risk given the current viral pandemic. We share our experience in managing minimally symptomatic, enlarging subdural collections via middle meningeal embolization through the outpatient setting. This approach minimizes inpatient hospitalizations in hopes or reducing nosocomial spread (e.g., of COVID-19).

Keywords: Chronic subdural hematoma, COVID-19, middle meningeal artery embolization, outpatient

Introduction

Chronic subdural hematomas (SDH) are typically found on follow-up imaging of known acute SDHs or through evaluations for headaches or falls, particularly in elderly patients.13 Expanding collections often require inpatient management in symptomatic patients. However, with the current SARS-CoV-19 (COVID-19) pandemic, our practice has increasingly shifted the management of mildly symptomatic patients with minimal hematoma expansion to the outpatient setting to avoid inpatient hospitalization.

Patients with large symptomatic lesions may be offered a procedure for hematoma evacuation, either through bedside evacuation using a small burr hole, or an operation via burr hole(s) or traditional craniotomy.4,5 Conversely, patients with small, minimally symptomatic lesions can be observed with serial imaging in the hope that the collections will spontaneously resorb.

The most difficult treatment decisions we commonly encounter are:

  1. Large or growing collections that are minimally symptomatic.

  2. Small collections associated with persistent, severe headaches.

  3. Patients with subdural collections who require antithrombotic therapy.

In our practice (and in other centers around the country) we have increasingly used embolization of the middle meningeal artery (MMA) as the sole treatment for chronic expanding SDHs.613 The premise is based on the observation that the outer membrane of a chronic SDH parasitizes its blood supply from the MMA. Subsequently, embolization of this artery reduces the rate of flow through this fragile and porous vascular network and prevents further microhemorrhage and transudation of blood and fluid into the subdural space.1,14 The collection is then reabsorbed slowly over time, in many cases without surgical drainage. We present five patients in which we have managed a chronic SDH by embolization of the MMA as the sole treatment through the outpatient setting (Table 1), as proof of concept that this can be done safely. Avoiding an inpatient admission allows us to minimize the risk to the patient of an admission in the setting of COVID-19. All embolization procedures were performed under moderate conscious sedation via a transfemoral approach.

Table 1.

Patient summary.

Case Presenting symptom Anti-thrombotic/Anti-coagulant Pre-embolization treatments Indication
#1 Imaging follow-up Apixaban None ↑ Size, HA
#2 ↑ HA None SEPS ↑ Size
#3 Falls, HA Aspirin, Clopidogrel None ↑ Size, fatigue
#4 Falls, HA None None Severe HA
#5 Seizure None None ↑ Size, HA
#6 HA Clopidogrel None Recurrent bleed

HA: headache; SEPS: subdural evacuating port system.

Case presentations

Case 1: A 47 year old with history of seizure disorder and alcohol abuse, on anticoagulation (apixaban), presented to the Emergency Department after a fall. He had no focal clinical deficits, but computed tomography (CT) for trauma workup revealed a small acute SDH (Figure 1(a)). Anticoagulation was held and the patient was discharged after observation. He was rescanned 3 weeks later showing enlargement of the collection (Figure 1(b)). A third scan 1 week later was stable (not shown) and the patient was restarted on apixaban. However, the patient returned one month later complaining of headaches, with acute blood on imaging (Figure 1(c)). Anticoagulation was again stopped and the patient was offered burr hole drainage, but refused. He was referred for MMA embolization. The embolization was performed under conscious sedation as an outpatient admission. He patient was discharged 2 hours post-procedure after resuming anticoagulation. Follow up imaging at 6 weeks, 5 months, and 12 months post-embolization showed resolution (Figure 1(d) to (f)). No further treatment was required.

Figure 1.

Figure 1.

Forty-seven year old (a) initially with a small SDH on CT, (b) showing slight enlargement after three weeks. (c) Acute blood developed once anticoagulation was restarted. MMA embolization was performed and imaging at (d) 6 weeks, (e) 5 months, and (f) 12 months post-embolization showed resolution.

Case 2: A 61 year old male was evaluated by a neurologist after complaining of headaches for 3 weeks. Magnetic resonance imaging (MRI) confirmed a chronic SDH over the left convexity (Figure 2(a)). The collection was drained via a twist drill craniotomy (Figure 2(b)). One month after drainage the patient continued to have headaches and a recurrent SDH was found (Figure 2(c)). Follow up CT two weeks later showed slight enlargement of the collection and increased midline shift (Figure 2(d)). Embolization of the left MMA was performed, with contrast-staining of the collection following the procedure (Figure 2(e)). Follow up imaging at 1, 3, and 6 months (Figure 2(f) to (h)) show progressive reabsorption.

Figure 2.

Figure 2.

Sixty-one year old (a) with a chronic SDH over the left convexity on MRI, (b) drained via a twist drill craniotomy. (c) Recurrence was seen after one month, (d) with enlargement after two weeks. Embolization was performed, (e) with contrast staining of the collection following the procedure. Progressive reabsorption at (f) 1, (g) 3, and (h) 6 months is shown.

Case 3: An 87 year old on aspirin and clopidogrel for coronary artery disease complained of headaches, recurrent falls, and cognitive decline, leading to discovery of a small mixed density SDH (Figure 3(a)). Antiplatelet agents were held, but progressive enlargement was seen at 1 and 3 weeks (Figure 3(b) and (c)). At 4 weeks the patient developed vomiting and fatigue and a new punctate hemorrhage was found (Figure 3(d)). Embolization of the MMA was performed (Figure 3(e)). Imaging 1 month post-procedure showed complete resolution of the subdural collection (3F). Antiplatelet agents were resumed.

Figure 3.

Figure 3.

Eighty-seven year old (a) with mixed density SDH, enlarging at (b) 1 and (c) 3 weeks, and (d) ultimately developing a new punctate hemorrhage. (e) Embolization of the MMA was performed, (f) with resolution of the collection at one month.

Case 4: A 78 year old female fell on her assist scooter while recovering from an ankle injury. She suffered no loss of consciousness or apparent neurological injury but suffered headaches for a week following. While her CT remained negative (Figure 4(a)), a follow-up MRI for continued intractable headaches revealed a small subdural collection (Figure 4(b)). Embolization of the right MMA was performed. The patient had immediate headache relief. The patient’s symptoms and collection (Figure 4(c)) were both resolved at 2 month follow-up.

Figure 4.

Figure 4.

Seventy-eight year old (a) with a negative outside hospital CT following trauma but (b) a small subdural collection on MRI. (c) Collection resolved on imaging two months following MMA embolization.

Case 5: 70 year old was admitted through the ED with a single, brief episode of aphasia and dysarthria. The patient reported a fall 5 days prior to admission. CT revealed a mostly acute appearing right convexity SDH (Figure 5(a)). He was started on levetiracetam and discharged home 2 days later. He had a follow up scan 2 weeks later showing growth and maturation of the collection (Figure 5(b)). He developed progressive headaches and CT scan several months later revealed enlargement of the collection (Figure 5(c)). Embolization was performed (Figure 5(d) to (e)) and post-procedure CT 3 weeks later showed substantial improvement (Figure 5(f)).

Figure 5.

Figure 5.

Seventy year old (a) with mixed density right convexity SDH, showing growth and maturation of the collection (b) at two weeks and (c) several months later. Embolization was performed (d to e) with contrast staining seen following the procedure, (f) and post-procedure CT 3 weeks later showed substantial improvement.

Discussion

Mixed density hemorrhagic collections over one or both convexities are commonly discovered on outpatient imaging performed for the workup of headaches or other neurological complaints. These chronic SDHs are typically traced back to a fall or other minor trauma.2 A patient with a small collection and minor or resolving symptoms may be managed expectantly with serial imaging, as in many cases these collections will resolve, on their own while those with large symptomatic lesions are typically offered surgical drainage.1

In some cases, patients with SDHs that were initially small will demonstrate growth of the collection over time rather than resolution, requiring treatment. The source of growth is attributed to microhemorrhages from the fragile vascular network found in the outer membrane.1,15,16 The events that lead to the formation of a chronic SDH are still debated (we prefer the model proposed by Haines et al.17), but one thing is certain: every expanding chronic SDH is made up of two parts, (1) the initial, evolving hemorrhage and (2) the continuing hemorrhage.1

Surgical drainage – via either a burr hole craniotomy or mini-craniotomy – can leave behind most, if not all, of the vascular outer membrane. Predictably, this method carries a high rate of recurrence.5,11,18 Embolization, on the other hand, can prevent ongoing hemorrhage of the outer membrane by disconnecting this blood supply, allowing for spontaneous reabsorption of the collection over time of clots that were previously expanding in the outpatient setting. This is particularly helpful in patients requiring antithrombotic therapy, as seen in our cohort.

In our practice, we consider outpatient embolization for patients who present with mild symptoms (such as headaches, gait imbalance, mild weakness, etc.) who are in a safe living environment. The procedure is well tolerated with small doses of versed and fentanyl for sedation. Local sedation is given to the puncture site as well. We use particles for our embolic material, and close with either an Angioseal if done via groin puncture or a TransRadial (TR) band if performed transradially (Terumo Interventional Systems, Somerset, NJ, USA). We monitor the patients for 2 hours post-operatively, examining them for neurological changes (particularly concerning vision) or procedural complications (such as groin/wrist hematoma, progressive headaches, nausea, vomiting, or medication reactions) prior to discharging them home from our post-procedural area. While the outpatient plan is discussed prior to the procedure, should the patient feel uncomfortable about discharge or develop signs of complications afterwards they would be admitted.

Middle meningeal artery embolization is relatively painless and can be done under conscious sedation with minimal risk of delayed complications.6,7 This procedure is amenable to a transradial approach in select patients, furthering its potential as an outpatient procedure. In our experience, MMA embolization can be performed safely as an outpatient procedure. Furthermore, eliminating the overnight (or longer) inpatient stay following surgical SDH evacuation improves patient comfort and may reduce the risk of iatrogenic complications, especially in an era where patients are at risk of contracting viridae such as COVID-19 from interactions within the hospital.

COVID-19 has severely limited the resources and hospital capacity available for the managing non-urgent surgical diseases across subspecialties.19,20 Elderly patients – the same ones who are at most risk for developing chronic SDHs – are at increased risk from the virus, and efforts should be made to limit their time as an inpatient due to the risk of nosocomial spread.2124 The lessons learned here may encourage providers to employ similar principles to endovascular procedures and consider outpatient treatment for other diagnosis as well (given appropriate monitoring protocols).

Conclusion

Our initial impression of MMA embolization as a primary treatment for chronic expanding subdural hematomas in the outpatient setting is that it is safe. Given the current viral pandemic, outpatient management of elderly patients is an attractive option, providing neurosurgeons the ability to procedurally manage patients with progressive hemorrhage while minimizing or eliminating the length of inpatient admission.

Footnotes

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding: The author(s) received no financial support for the research, authorship, and/or publication of this article.

References

  • 1.Moshayedi P, Liebeskind DS.Middle meningeal artery embolization in chronic subdural hematoma: implications of pathophysiology in trial design. Front Neurol 2020; 11: 923–909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Shapey J, Glancz LJ, Brennan PM.Chronic subdural haematoma in the elderly: is it time for a new paradigm in management? Curr Geriatr Rep 2016; 5: 71–77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Kolias AG, Chari A, Santarius T, et al. Chronic subdural haematoma: modern management and emerging therapies. Nat Rev Neurol 2014; 10: 570–578. [DOI] [PubMed] [Google Scholar]
  • 4.Dumont TM, Rughani AI, Goeckes T, et al. Chronic subdural hematoma: a sentinel health event. World Neurosurg 2013; 80: 889–892. [DOI] [PubMed] [Google Scholar]
  • 5.Gelabert-Gonzalez M, Iglesias-Pais M, Garcia-Allut A, et al. Chronic subdural haematoma: surgical treatment and outcome in 1000 cases. Clin Neurol Neurosurg 2005; 107: 223–229. [DOI] [PubMed] [Google Scholar]
  • 6.Tempaku A, Yamauchi S, Ikeda H, et al. Usefulness of interventional embolization of the middle meningeal artery for recurrent chronic subdural hematoma: five cases and a review of the literature. Interv Neuroradiol 2015; 21: 366–371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Fiorella D, Arthur AS.Middle meningeal artery embolization for the management of chronic subdural hematoma. J Neurointerv Surg 2019; 11: 912–915. [DOI] [PubMed] [Google Scholar]
  • 8.Link TW, Rapoport BI, Paine SM, et al. Middle meningeal artery embolization for chronic subdural hematoma: endovascular technique and radiographic findings. Interv Neuroradiol 2018; 24: 455–462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Ban SP, Hwang G, Byoun HS, et al. Middle meningeal artery embolization for chronic subdural hematoma. Radiology 2018; 286: 992–999. [DOI] [PubMed] [Google Scholar]
  • 10.Srivatsan A, Srinivasan VM, Thomas A, et al. Perspective on safety and effectiveness of middle meningeal artery embolization for chronic subdural hematoma. World Neurosurg 2019; 127: 97–98. [DOI] [PubMed] [Google Scholar]
  • 11.Haldrup M, Ketharanathan B, Debrabant B, et al. Embolization of the middle meningeal artery in patients with chronic subdural hematoma – a systematic review and meta-analysis. Acta Neurochir 2020; 162: 777–784. [DOI] [PubMed] [Google Scholar]
  • 12.Jumah F, Osama M, Islim AI, et al. Efficacy and safety of middle meningeal artery embolization in the management of refractory or chronic subdural hematomas: a systematic review and meta-analysis. Acta Neurochir 2020; 162: 499–507. [DOI] [PubMed] [Google Scholar]
  • 13.Entezami P, Boulos A, Paul A, et al. Contrast enhancement of chronic subdural hematomas after embolization of the middle meningeal artery. Interv Neuroradiol 2019; 25: 596–600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Edlmann E, Giorgi-Coll S, Whitfield PC, et al. Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy. J Neuroinflammation 2017; 14: 108–106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Sato S, Suzuki J.Ultrastructural observations of the capsule of chronic subdural hematoma in various clinical stages. J Neurosurg 1975; 43: 569–578. [DOI] [PubMed] [Google Scholar]
  • 16.Moskala M, Goscinski I, Kaluza J, et al. Morphological aspects of the traumatic chronic subdural hematoma capsule: SEM studies. Microsc Microanal 2007; 13: 211–219. [DOI] [PubMed] [Google Scholar]
  • 17.Haines DE, Harkey HL, Al-Mefty O.The “subdural” space: a new look at an outdated concept. Neurosurgery 1993; 32: 111–120. [DOI] [PubMed] [Google Scholar]
  • 18.Nakaguchi H, Tanishima T, Yoshimasu N.Relationship between drainage catheter location and postoperative recurrence of chronic subdural hematoma after burr-hole irrigation and closed-system drainage. J Neurosurg 2000; 93: 791–795. [DOI] [PubMed] [Google Scholar]
  • 19.Gilat R, Haunschild ED, Tauro T, et al. Recommendation to optimize safety of elective surgical care while limiting the spread of COVID-19: primum non nocere. Arthrosc Sports Med Rehabil 2020 2020/04/29 DOI: 10.1016/j.asmr.2020.04.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Massey PA, McClary K, Zhang AS, et al. Orthopaedic surgical selection and inpatient paradigms during the coronavirus (COVID-19) pandemic. J Am Acad Orthop Surg 2020; 28: 436–450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Daoust JF.Elderly people and responses to COVID-19 in 27 countries. PLoS One 2020; 15: e0235590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Perrotta F, Corbi G, Mazzeo G, et al. COVID-19 and the elderly: insights into pathogenesis and clinical decision-making. Aging Clin Exp Res 2020; 32: 1599–1608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Rickman HM, Rampling T, Shaw K, et al. Nosocomial transmission of COVID-19: a retrospective study of 66 hospital-acquired cases in a London teaching hospital. Clin Infect Dis. Epub ahead of print 21 June 2020. DOI: 10.1093/cid/ciaa816 [DOI] [PMC free article] [PubMed]
  • 24.Wong SCY, Kwong RT, Wu TC, et al. Risk of nosocomial transmission of coronavirus disease 2019: an experience in a general ward setting in Hong Kong. J Hosp Infect 2020; 105: 119–127. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Interventional Neuroradiology are provided here courtesy of SAGE Publications

RESOURCES